Numbers of subjects that tested positive at baseline to at least one test- at high cut-off, in several combinations of tests (n = 1,600) and numbers of VL cases that developed among those.</p
<p>Number of patients that can be manipulated before, on average, the manipulation is detected by th...
<p>Numbers of Subjects Who Changed From Initial High Risk to Low Risk and From Initial Low Risk to H...
Positivity rates of the three diagnostic methods used for the 114 sampled patients.</p
<p>Number of extra false positives per true positive for varying levels of prevalence and prior dete...
<p>Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95...
<p>Number of positive patient samples using comparing alternative scoring probe-wise, gene-wise and ...
Total positive cases (n = 54) and percentage of observed clinical features in them.</p
<p>The number of true positives and false positives identified in different methods.</p
Number of true positives (TP) and false positives (FP) found in the different simulations: with and ...
<p>Number of positive test results combining RDTs with trypanolysis, by type of study participant.</...
Number of positive cases by each test during treatment among sputum specimens with MGIT data in Stud...
Number of positive cases by LAM-ELISA and MGIT culture on days 28 and 56 in Study 2.</p
<p>Serologic titers are graphed for the 12,634 subjects without prior or current VL, measured by the...
<p>Number of patients whose outcome scores exceeded the MCID thresholds, expressed as the percentage...
<p>Number of samples positive using apparent and true prevalence, by species and age.</p
<p>Number of patients that can be manipulated before, on average, the manipulation is detected by th...
<p>Numbers of Subjects Who Changed From Initial High Risk to Low Risk and From Initial Low Risk to H...
Positivity rates of the three diagnostic methods used for the 114 sampled patients.</p
<p>Number of extra false positives per true positive for varying levels of prevalence and prior dete...
<p>Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95...
<p>Number of positive patient samples using comparing alternative scoring probe-wise, gene-wise and ...
Total positive cases (n = 54) and percentage of observed clinical features in them.</p
<p>The number of true positives and false positives identified in different methods.</p
Number of true positives (TP) and false positives (FP) found in the different simulations: with and ...
<p>Number of positive test results combining RDTs with trypanolysis, by type of study participant.</...
Number of positive cases by each test during treatment among sputum specimens with MGIT data in Stud...
Number of positive cases by LAM-ELISA and MGIT culture on days 28 and 56 in Study 2.</p
<p>Serologic titers are graphed for the 12,634 subjects without prior or current VL, measured by the...
<p>Number of patients whose outcome scores exceeded the MCID thresholds, expressed as the percentage...
<p>Number of samples positive using apparent and true prevalence, by species and age.</p
<p>Number of patients that can be manipulated before, on average, the manipulation is detected by th...
<p>Numbers of Subjects Who Changed From Initial High Risk to Low Risk and From Initial Low Risk to H...
Positivity rates of the three diagnostic methods used for the 114 sampled patients.</p